Sharekhan

Aarey Drugs and Pharmaceuticals Ltd

Thu 13/03/2025,15:58:14 | NSE : AAREYDRUGS

₹ 36.51-0.67 (-1.80%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 36.30

Previous Close

₹ 37.18

Volume

68205

Mkt Cap ( Rs. Cr)

₹103.52

High

₹ 40.80

Low

₹ 35.91

52 Week High

₹ 74.80

52 Week Low

₹ 35.70

Book Value Per Share

₹ 46.93

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Aarey Drugs and Pharmaceuticals Ltd

Your Vote -

Buy

71.43%

Hold

14.29%

Sell

14.29%

71.43%

28 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

36.51

2

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

2

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Aarey Drugs and Pharmaceuticals Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Aarey Drugs & Ph - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    6 Mar 2025, 5:22PM AAREY DRUGS & PHARMACEUTICALS LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Shar
  • Aarey Drugs & Ph - Change in Company Secretary/Compliance Officer

    6 Mar 2025, 5:11PM Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about Change in Company Secretary/Compliance Officer
  • Aarey Drugs & Ph - Change in Company Secretary/Compliance Officer

    6 Mar 2025, 5:06PM Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about Change in Company Secretary/Compliance Officer
  • Aarey Drugs & Ph - Outcome of Board Meeting

    6 Mar 2025, 4:43PM Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on March 06, 2025 Intimation regarding appointment of C
  • Aarey Drugs & Ph - Announcement under Regulation 30 (LODR)-Change in Management

    6 Mar 2025, 4:54PM Intimation regarding appointment of Company Secretary and Compliance Officer of the Company under Regulation 30 of the SEBI (Listing Obligations and D
  • Aarey Drugs & Ph - Appointment of Company Secretary and Compliance Officer

    6 Mar 2025, 4:48PM Intimation regarding appointment of Company Secretary and Compliance Officer of the Company under Regulation 30 of the SEBI (Listing Obligations and D
  • Aarey Drugs & Ph - Board Meeting Outcome for Intimation Regarding Appointment Of 'Company Secretary And Compliance Officer'

    6 Mar 2025, 4:40PM Pursuant to Regulation 30 of the Securities and Exchange Board of India (SEBI) (Listing Obligations and Disclosure Requirements) Regulations, 2015 rea
  • Aarey Drugs & Ph - Board Meeting Outcome for Intimation Regarding Appointment Of 'Company Secretary And Compliance Officer'

    6 Mar 2025, 4:40PM Pursuant to Regulation 30 of the Securities and Exchange Board of India (SEBI) (Listing Obligations and Disclosure Requirements) Regulations, 2015 rea
  • Aarey Drugs & Ph - Board Meeting Outcome for Intimation Regarding Appointment Of 'Company Secretary And Compliance Officer'

    6 Mar 2025, 4:40PM Pursuant to Regulation 30 of the Securities and Exchange Board of India (SEBI) (Listing Obligations and Disclosure Requirements) Regulations, 2015 rea
  • Aarey Drugs & Ph - Board Meeting Outcome for Intimation Regarding Appointment Of 'Company Secretary And Compliance Officer'

    6 Mar 2025, 4:40PM Pursuant to Regulation 30 of the Securities and Exchange Board of India (SEBI) (Listing Obligations and Disclosure Requirements) Regulations, 2015 rea
  • Aarey Drugs & Ph - Board Meeting Outcome for Intimation Regarding Appointment Of 'Company Secretary And Compliance Officer'

    6 Mar 2025, 4:40PM Pursuant to Regulation 30 of the Securities and Exchange Board of India (SEBI) (Listing Obligations and Disclosure Requirements) Regulations, 2015 rea
  • Aarey Drugs & Ph - Board Meeting Outcome for Intimation Regarding Appointment Of 'Company Secretary And Compliance Officer'

    6 Mar 2025, 4:40PM Pursuant to Regulation 30 of the Securities and Exchange Board of India (SEBI) (Listing Obligations and Disclosure Requirements) Regulations, 2015 rea
  • Aarey Drugs & Ph - Board Meeting Outcome for Intimation Regarding Appointment Of 'Company Secretary And Compliance Officer'

    6 Mar 2025, 4:40PM Pursuant to Regulation 30 of the Securities and Exchange Board of India (SEBI) (Listing Obligations and Disclosure Requirements) Regulations, 2015 rea
  • Aarey Drugs & Ph - Board Meeting Outcome for Intimation Regarding Appointment Of 'Company Secretary And Compliance Officer'

    6 Mar 2025, 4:40PM Pursuant to Regulation 30 of the Securities and Exchange Board of India (SEBI) (Listing Obligations and Disclosure Requirements) Regulations, 2015 rea
  • Aarey Drugs & Ph - Integrated Filing- Financial

    17 Feb 2025, 2:07PM Integrated financial filing
  • Aarey Drugs & Ph - Integrated Filing (Financial)

    17 Feb 2025, 2:14PM integrated filing
  • Aarey Drugs & Ph Q3 net profit down 29.41% at Rs 0.72 cr

    14 Feb 2025, 8:40PM The company reported standalone net profit of Rs 0.72 crore for the quarter ended December 31, 2024 as compared to Rs 1.02 crore in the same period la
  • Aarey Drugs & Ph - Unaudited Financial Result For December 2024

    14 Feb 2025, 7:12PM Unaudited Financial Result for December 2024
  • Aarey Drugs & Ph - Financial Result Updates

    14 Feb 2025, 7:06PM Aarey Drugs & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024.
  • Aarey Drugs & Ph - Board Meeting Outcome for Outcome

    14 Feb 2025, 7:06PM outcome
  • Aarey Drugs & Ph - Board Meeting Intimation

    6 Feb 2025, 1:04PM AAREY DRUGS & PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 14-Feb-2025 to inter-alia consider and approve the U
  • Aarey Drugs & Ph - Board Meeting Intimation for Quarterly Financial Result

    6 Feb 2025, 1:03PM AAREY DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 ,inter alia, t
  • Aarey Drugs & Ph has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2024

    13 Jan 2025, 6:10PM As of December 2024, 44.80% is owned by Indian Promoters and 55.20% by Public. <p align=justify> Top five Promoters holding highest number of shares o
  • Aarey Drugs & Ph - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    8 Jan 2025, 7:06PM Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Aarey Drugs & Ph - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    8 Jan 2025, 7:01PM Reg 74(5) of SEBI (DP) Regulations, 2018
  • Aarey Drugs & Ph - General Updates

    8 Jan 2025, 4:52PM Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about change of RTA name
  • Aarey Drugs & Ph - Announcement under Regulation 30 (LODR)-Change in RTA

    8 Jan 2025, 4:48PM Change of RTA name
  • Aarey Drugs & Ph - Resignation

    2 Jan 2025, 2:24PM Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding Resignation of Mrs as Company Secretary & Compliance Officer of the company
  • Aarey Drugs & Ph - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    2 Jan 2025, 2:14PM AAREY DRUGS & PHARMACEUTICALS LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Shar
  • Aarey Drugs & Ph - Outcome of Board Meeting

    2 Jan 2025, 2:12PM Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on January 02, 2025.
  • Aarey Drugs & Ph - Shareholders meeting

    2 Jan 2025, 1:53PM Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on January 02, 2025
  • Aarey Drugs & Ph - Announcement under Regulation 30 (LODR)-Cessation

    2 Jan 2025, 2:20PM Reg 30 of SEBI (Listing Obligation and Disclosure Requirements)- Resignation of Company Secretary
  • Aarey Drugs & Ph - Board Meeting Outcome for Outcome

    2 Jan 2025, 2:10PM Outcome
  • Aarey Drugs & Ph - Copy of Newspaper Publication

    30 Dec 2024, 8:01PM Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication
  • Aarey Drugs & Ph - Corrigendum

    27 Dec 2024, 6:10PM Corrigendum
  • Aarey Drugs & Ph - Corrigendum

    27 Dec 2024, 6:07PM Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding Corrigendum to Notice of Extra Ordinary General Meeting
  • Aarey Drugs & Ph - Trading Window-XBRL

    24 Dec 2024, 6:05PM Aarey drugs & Pharmaceuticals Limited has informed the Exchange about Closure of Trading Window
  • Aarey Drugs & Ph - Trading Window

    24 Dec 2024, 5:59PM Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading)
  • Aarey Drugs board to reconsider stock split

    6 Oct 2017 , 1:25PM Aarey Drugs surges over 14% to Rs87.9, as board to meet on October 12, 2017 to reconsider stock split proposal

Key fundamentals

Evaluate the intrinsic value of Aarey Drugs and Pharmaceuticals Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 164.1257 155.1265 127.7997 116.8776 110.2337
Liabilities 164.1257 155.1265 127.7997 116.8776 110.2337
Equity 28.0543 25.3847 25.3846 23.3846 23.3846
Gross Profit 4.4513 7.7213 11.2678 4.6387 3.2321
Net Profit 4.6837 3.7712 6.5447 6.5143 5.7935
Cash From Operating Activities -2.9938 -1.2811 -4.493 5.4769 2.8572
NPM(%) 1.18 0.9 1.32 1.86 1.93
Revenue 395.6179 418.9562 492.6799 348.4164 300.0888
Expenses 391.1666 411.2349 481.4121 343.7776 296.8566
ROE(%) 3.51 2.83 4.91 4.89 4.35

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Aarey Drugs and Pharmaceuticals Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 808.20 -1.14 11.41 20.83 1321.50 1.42
Lotus Eye Hospital and Institute Ltd 57.06 -0.77 237.75 75.89 14.01 0.88
Vaishali Pharma Ltd 12.12 -5.90 606.00 39.11 2.31 0.00
Astec Lifesciences Ltd 653.90 -5.55 0.00 71.55 -239.30 0.00

Company Info

Aarey Drugs & Pharmaceuticals Ltd. (ADPL) was originally incorporated as a private limited company in the name of Niharika Textiles & Chemicals Pvt. Ltd. on 15th May 1990. The Aarey group of companie belonging to the Ghatalia group of companies took over the company and converted it into a public limited company on 18th march 1993. Its name was since changed to Aarey Drugs & Pharmaceuticals Ltd. The main object of the company is to set up facilities for manufacture of bulk drugs. As an immediate step the company has undertaken a project to manufacture Metronidazole and Metronidazole Benzoate at its works situated at E-34, MIDC Estate. 2008 -Aarey Drugs & Pharmaceuticals Ltd has appointed Mr. Chetan Kiritbhai Mehta as an Independent Director of the Company from June 02, 2008. 2012 -Aarey Drugs & Pharmaceuticals Ltd Issues Rights in the Ratio of 2:1 -Aarey Drugs & Pharmaceuticals has given the Bonus in the Ratio of 1:5 2017 -The company has commenced production of new line of product Mefanamic Acid and has confirmed order for the same from its customers up till October, 2017.

Aarey Drugs & Pharmaceuticals Ltd. (ADPL) was originally incorporated as a private limited company in the name of Niharika Textiles & Chemicals Pvt. Ltd. on 15th May 1990. The Aarey group of companie belonging to the Ghatalia group of companies took over the company and converted it into a public limited company on 18th march 1993. Its name was since changed to Aarey Drugs & Pharmaceuticals Ltd. The main object of the company is to set up facilities for manufacture of bulk drugs. As an immediate step the company has undertaken a project to manufacture Metronidazole and Metronidazole Benzoate at its works situated at E-34, MIDC Estate. 2008 -Aarey Drugs & Pharmaceuticals Ltd has appointed Mr. Chetan Kiritbhai Mehta as an Independent Director of the Company from June 02, 2008. 2012 -Aarey Drugs & Pharmaceuticals Ltd Issues Rights in the Ratio of 2:1 -Aarey Drugs & Pharmaceuticals has given the Bonus in the Ratio of 1:5 2017 -The company has commenced production of new line of product Mefanamic Acid and has confirmed order for the same from its customers up till October, 2017.

Read More

Parent Organisation

Aarey Drugs & Pharmaceuticals Ltd.

Founded

15/05/1990

Managing Director

Mr.Mihir R Ghatalia

NSE Symbol

AAREYDRUGSEQ

FAQ

The current price of Aarey Drugs and Pharmaceuticals Ltd is ₹ 36.51.

The 52-week high for Aarey Drugs and Pharmaceuticals Ltd is ₹ 40.80 and the 52-week low is ₹ 35.91.

The market capitalization of Aarey Drugs and Pharmaceuticals Ltd is currently ₹ 103.52. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Aarey Drugs and Pharmaceuticals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Aarey Drugs and Pharmaceuticals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Aarey Drugs and Pharmaceuticals Ltd shares.

The CEO of Aarey Drugs and Pharmaceuticals Ltd is Mr.Mihir R Ghatalia, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT